Novo Nordisk braces for Ozempic rivals in China | REUTERS

Novo Nordisk is facing the prospect of intensifying competition in the Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed.

#novonordisk #wegovyweightloss #wgovy #ozempicweightloss #ozempic #china #drugmakers #News #Reuters #Newsfeed

Read the story here: https://reut.rs/3KCS3gN

Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en